Tag Archives: pharmaceutical industry

Feds Threaten to Pull ProAmatine for Lack of Postmarket Data (Updated 8/18)

By George Koroneos | Published: August 16, 2010
Image via Wikipedia FDA on Monday announced that it was looking to withdraw approval for the low-blood-pressure treatment midodrine hydrochloride because the companies manufacturing the drug failed to provide data from post-approval studies. The kicker: The drug was approved 14 years ago. FDA gave midodrine hydrochloride—branded by Shire as ProAmatine and produced by a half-dozen generics firms—the green [...]
Posted in FDA | Also tagged , , , , , , , | Leave a comment

AZ Celebrates Crestor Patent Win

By George Koroneos | Published: June 30, 2010
The US District Court in Delaware upheld AstraZeneca’s patent for its blockbuster statin Crestor (rosuvastatin), ending a dispute that could have crippled the drugmaker’s billion-dollar cash cow. Crestor’s patent is not scheduled to expire until 2016. However, a group of generics firms had claimed that a substance patent (314) protecting one of the active ingredients in [...]
Posted in Legal | Also tagged , , , , , , | Leave a comment

Takeda Launches New Plan, Cuts US Jobs

By George Koroneos | Published: May 13, 2010
Image via Wikipedia The Japanese are taking a play from the US pharmaceutical industry’s rulebook and restructuring itself under the auspices of a fun catch phrase: “Transformation for a New Takeda.” The punch line, however, isn’t too funny. According to a two-year mid-range plan announced yesterday, Takeda will cut about 1,400 positions in the US to fend off [...]
Posted in Strategy | Also tagged , , , , , , , | Leave a comment

Patient Adherence Awards Winners Revealed

By George Koroneos | Published: April 28, 2010
Image via Wikipedia The Center for Business Intelligence, on Monday, revealed winners of its annual Strategic Patient Adherence Awards as part of its two-day conference about patient compliance with their drug regiments. This year’s award winners are: Best Integrated Program—Shire Pharmaceuticals: FOSRENOL ON TRACK Direct To Patient Support Program Best Disease State Program—BMS/Sanofi-Aventis Canada & Rx Canada: My Plavix [...]
Posted in Events, Strategy | Also tagged , , , , , , , , | Leave a comment

PhRMA’s Tauzin Calls it a Day

By George Koroneos | Published: February 12, 2010
PhrMA President and CEO Billy Tauzin announced on Friday that he will step down from his post after five years with the pharmaceutical lobby group. The move comes amid speculation that the President’s healthcare reform bill has stalled in Congress thanks in part to the recent Republican Senate win in Massachusetts. Tauzin was an integral part [...]
Posted in People | Also tagged , , , , | Leave a comment